Charcot-Marie-Tooth Disease, Type 1A

Rare Disease·MeSH: Charcot-Marie-Tooth Disease

Prevalence

30.0 / 100K

2 drugs in development·2 companies·1 clinical trial

Drug Pipeline by Phase

Frequently asked questions

How many drugs are in development for Charcot-Marie-Tooth Disease, Type 1A?

BioSniper tracks 2 drugs in development for Charcot-Marie-Tooth Disease, Type 1A across 2 companies.

How many clinical trials target Charcot-Marie-Tooth Disease, Type 1A?

There are 1 clinical trial targeting Charcot-Marie-Tooth Disease, Type 1A tracked by BioSniper.

What is the prevalence of Charcot-Marie-Tooth Disease, Type 1A?

The estimated prevalence of Charcot-Marie-Tooth Disease, Type 1A is approximately 30.0 per 100,000 population.

Deep-dive into Charcot-Marie-Tooth Disease, Type 1A

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Charcot-Marie-Tooth Disease, Type 1A — Drugs in Development & Clinical Trials | BioSniper